ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Clinical practice"

  • Abstract Number: 109 • 2020 Pediatric Rheumatology Symposium

    Incidence, Contributing Factors, and Impact of Diagnostic Delay in Juvenile Idiopathic Arthritis: Analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry

    Mei-Sing Ong1, Gordon Schiff 2 and Marc Natter 3 for the CARRA investigators, 1Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, 2Harvard Medical School, Boston, 3Boston Children's Hospital, Boston

    Background/Purpose: While early treatment of patients with newly diagnosed juvenile idiopathic arthritis (JIA) is an area of active study, delayed diagnosis of JIA is poorly…
  • Abstract Number: 191 • 2020 Pediatric Rheumatology Symposium

    Utilization of Telemedicine in Pediatric Rheumatologic Care

    Rajdeep Pooni1 and Tzielan Lee 1, 1Stanford Children's, Palo Alto

    Background/Purpose: Telemedicine has the potential for improving access to care, particularly for pediatric patients with complex needs in remote or rural locations. Previous studies have…
  • Abstract Number: 302 • 2019 ACR/ARP Annual Meeting

    Clinical Impact of a Rheumatology Musculoskeletal Ultrasound Clinic at a U.S. Academic Center

    Sarah Chung1, Katherine Wysham 2, Elizabeth Jernberg 3, Ingeborg Sacksen 3, Scott Pollock 1 and Alison Bays 1, 1University of Washington Division of Rheumatology, Seattle, WA, 2Veterans Health Administration Puget Sound, Seattle WA, Seattle, 3University of Washington Division of Rheumatology, Seattle

    Background/Purpose: Routine use of musculoskeletal ultrasound (MSK-US) to aid in clinical decision-making for rheumatology patients is less common in the United States than in Europe,…
  • Abstract Number: 654 • 2019 ACR/ARP Annual Meeting

    Applying Systemic Lupus International Collaborating Clinics (SLICC) and Provisional ACR/EULAR Systemic Lupus Erythematosus Classification Criteria in a Cohort of Patients with Undifferentiated Connective Tissue Disease

    Kyle Drehmel1, Alan Erickson 1, Bryant England 2 and Michelene Hearth-Holmes 1, 1University of Nebraska Medical Center, Omaha, NE, 2VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha

    Background/Purpose: Undifferentiated Connective Tissue Disease (UCTD) describes the clinical scenario where a patient demonstrates characteristics of a connective tissue disease but does not meet criteria…
  • Abstract Number: 1530 • 2019 ACR/ARP Annual Meeting

    Real World Effectiveness of Secukinumab in Patients with Ankylosing Spondylitis: Findings from a Recent Cross Sectional Survey of Rheumatologists and Patients in Europe

    Uta Kiltz 1, Elizabeth Holdsworth2, Haijun Tian 3, Nicola Booth 4, Papa Anthony 5, Lina Helsche 6, Dorothy Keininger 6 and Philip G Conaghan 7, 1Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, 2Adelphi Real World, Manchester, England, United Kingdom, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Adelphi Real World, Bollington, United Kingdom, 5Adelphi Real World, Macclesfield, England, United Kingdom, 6Novartis Pharma AG, Basel, Basel-Landschaft, Switzerland, 7Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom

    Background/Purpose: Ankylosing spondylitis (AS) can lead to reduced physical functioning and quality of life.  Secukinumab has demonstrated clinical benefits in AS patients in clinical trials1-2.…
  • Abstract Number: 2461 • 2019 ACR/ARP Annual Meeting

    Clinical Presentation and Treatment of Oligoarticular Psoriatic Arthritis in Canada: High Frequency of Smaller Joint Involvement

    Alfred Cividino1, Denise Nicholson 2, Sherif Guindi 2, Jennifer Jelley 2, Anne-Julie Gaudreau 2 and Dafna Gladman 3, 1McMaster University's Faculty of Health Sciences, Hamilton, ON, Canada, 2Celgene Corporation, Summit, NJ, 3University of Toronto, Toronto, ON, Canada

    Background/Purpose: Oligoarticular disease in patients with psoriatic arthritis (PsA) is often underdiagnosed and undertreated. The goal of this study is to understand and identify current…
  • Abstract Number: 2524 • 2019 ACR/ARP Annual Meeting

    24-Month Outcomes Associated with Belimumab in Black/African-American Patients with Systemic Lupus Erythematosus in a Clinical Practice Setting in the United States

    Christopher Collins 1, Gail Kerr 2, Joan Von Feldt 3, Bernie Rubin 4, Arie Katz 3, Vanessa Castellano 5, Jake Chung 4 and Christopher Bell5, 1MedStar Washington Hospital Center, Department of Rheumatology, Washington, DC, 2Washington DC VA Medical Center, Georgetown and Howard Universities, Washington DC, DC, 3GSK, Philadelphia, PA, 4GSK, Phildelphia, PA, 5GSK, Research Triangle Park, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by diverse clinical manifestations and organ damage accrual. Black/African-American (B/AA) race is associated with…
  • Abstract Number: 2720 • 2019 ACR/ARP Annual Meeting

    Implementation of an Evidence-based Transition Clinic in a Pediatric Rheumatology Academic Institution

    Rebecca Overbury1, John Bohnsack 2, CJ Inman 3, Sara Stern 3, Karen James 3, Daniel Clegg 3, Tracy Frech 4 and Aimee Hersh 3, 1Assisstant Professor, University of Utah, Salt Lake City, UT, 2University of Utah School of Medicine, Salt Lake City, UT, 3University of Utah, Salt Lake City, UT, 4Division of Rheumatology, University of Utah and Salt Lake VAMC, Salt Lake City, UT

    Background/Purpose: Transition from pediatric to adult rheumatology care is more likely to be successful if a transition program is in place. Previously successful interventions to…
  • Abstract Number: 2796 • 2019 ACR/ARP Annual Meeting

    The Association Between Omega-3 Supplementation and Disease Activity in a Rheumatoid Arthritis (RA) Observational Cohort

    Adel Andemeskel1, Vivi Feathers 1, Christine Iannaccone 1, Jing Cui 1 and Nancy Shadick 1, 1Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Omega-3 supplementation is one of a few complementary and alternative medicine (CAM) therapies that has shown promise in improving RA symptoms through small, randomized…
  • Abstract Number: 621 • 2018 ACR/ARHP Annual Meeting

    Practical Optimization of Methotrexate Dose Improves Disease Control of Rheumatoid Arthritis Despite Reduction or Discontinuation of Oral Glucocorticoids

    Shintaro Hirata1, Kei Araki1, Hiroki Kohno1, Kazutoshi Yukawa1, Tadahiro Tokunaga1, Tatsuomi Kuranobu1, Katsuhiro Oi1, Yusuke Yoshida1, Tomohiro Sugimoto1, Keisuke Oda1,2, Takaki Nojima1,3 and Eiji Sugiyama1, 1Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan, 2Hiroshima Clinic, Hiroshima, Japan, 3Nojima Internal Medicine Clinic, Hiroshima, Japan

    Background/Purpose: Short-term glucocorticoids (GCs) along with methotrexate (MTX) has been recommended for newly onset patients with rheumatoid arthritis (RA) in EULAR recommendation 2016. However, it…
  • Abstract Number: 2890 • 2018 ACR/ARHP Annual Meeting

    Effect of Tapering of Tumor Necrosis Factor Inhibitor on Achieving Inactive Disease in Axial Spondyloarthritis Based on the ‘Treat-to-Target’ Strategy: A Nationwide Prospective Cohort Study

    Jun Won Park1, Min Jung Kim1, Hyoun-Ah Kim2, Kichul Shin3, Yong-Beom Park4, Yeong Wook Song5 and Eun Young Lee1, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of (South), 2Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea, Republic of (South), 3Kyungnam villa #102, Division of Rheumatology, Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of (South), 4Yonsei University College of Medicine, Seoul, Korea, Republic of (South), 5Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, Korea, Republic of (South)

    Background/Purpose: Although recent treatment guideline of axial spondyloarthritis (axSpA) by the European League Against Rheumatism (EULAR) recommended that tapering of tumor necrosis factor inhibitor (TNFi)…
  • Abstract Number: 1191 • 2018 ACR/ARHP Annual Meeting

    The Importance of Quantitative Assessment of Joint/Organ Damage and Patient Distress in Addition to Inflammatory Activity in Routine Clinical Care

    Theodore Pincus, Isabel Castrejón and Joel A. Block, Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Quantitative measures such as laboratory tests and pooled indices have advanced clinical rheumatology care far beyond narrative decisions. These measures generally are directed to…
  • Abstract Number: 1601 • 2018 ACR/ARHP Annual Meeting

    Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis: Results from a Cross-Sectional Observational Study in the United States

    Philip J. Mease1, Clive Liu2, Evan Siegel3,4, Heather Richmond5, Meijing Wu6, Liang Chen6, Kevin Douglas6 and Benjamin Lockshin7, 1Swedish Medical Center and University of Washington, Seattle, WA, 2Bellevue Dermatology Clinic, Bellevue, WA, 3Georgetown University, Washington, DC, 4Arthritis and Rheumatism Associates, Rockville, MD, 5Clear Dermatology, Houston, TX, 6AbbVie Inc., North Chicago, IL, 7US Dermatology Partners, Rockville, MD

    Background/Purpose: In patients (pts) with psoriatic arthritis (PsA), early diagnosis and effective treatment has been shown to decrease functional disability and structural progression (Gladman DD,…
  • Abstract Number: 1602 • 2018 ACR/ARHP Annual Meeting

    Disease Characteristics, Quality of Life, and Work Productivity By Enthesitis Sites: Real-World Data from the US Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry

    Philip J. Mease1, Mei Liu2, Sabrina Rebello3, Winnie Hua2, Robert R. McLean2, Peter Hur4 and Alexis Ogdie5, 1Swedish Medical Center and University of Washington, Seattle, WA, 2Corrona, LLC, Waltham, MA, 3Corrona, LLC, Southborough, MA, 4Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA, East Hanover, NJ, 5Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Prior studies showed psoriatic arthritis (PsA) patients with enthesitis had greater disease burden than patients without enthesitis, yet it is unknown whether the impact…
  • Abstract Number: 2155 • 2018 ACR/ARHP Annual Meeting

    Diagnosis of Systemic Sclerosis in the United Kingdom: An Observational Study Using the Clinical Practice Research Datalink

    Alicia Gayle1, Nils Schoof2, Margarida Alves2, Deborah Clarke3, Chris Poole1, Christina Raabe2, Prithwiraj Das1 and Toby Maher4, 1Boehringer Ingelheim Ltd., Bracknell, United Kingdom, 2Boehringer Ingelheim International GmbH, Ingelheim, Germany, 3Department of Medical Affairs, Boehringer Ingelheim Ltd., Bracknell, United Kingdom, 4University College London and Royal Brompton Hospital, London, United Kingdom

    Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune disease that is characterised by fibroblast dysfunction and excess extracellular matrix deposition that leads to skin thickening and…
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology